PAN AFRICAN JOURNAL OF LIFE SCIENCES
e-ISSN: 2672-5924
Volume 6, No. 3, December 2022
Pages 513-523
DOI: 10.36108/pajols/2202/60.0310
Predictors of Incomplete Adherence and Immuno-virologic Failure among HIV Infected Patients in Osun State, Nigeria
Bashirat Tolulope Shittu1, Oluyinka Oladele Opaleye 1*, Moses Olubusuyi Adewumi 2,
Mujeeb Olushola Shittu 3, Olusola Ojurongbe 1, Akinlawon Adetiloye Adepeju 4,
Kehinde Adesoji Adeniregun 5, James E Atolagbe 6 and Olugbenga A Olowe 1
1Department of Medical Microbiology and Parasitology, Ladoke Akintola University of Technology, Osogbo, Nigeria
2Department of Virology, College of Medicine, University College Hospital, University of Ibadan, Ibadan, Nigeria
3Department of Medical Laboratory Services, Chemical Pathology Unit, Ladoke Akintola University of Technology Teaching
Hospital, Ogbomoso, Nigeria
4Department of Medical Laboratory Services, Chemical Pathology Unit, Ladoke Akintola University of Technology Teaching
Hospital, Osogbo, Nigeria.
5Institute of Human Virology of Nigeria (IHVN), Lagos Region
6Department of Public Health, College of Postgraduate School, Adeleke University, Ede, Osun State, Nigeria
Abstract
BACKGROUND: To identify and address modifiable baseline clinical and non- clinical predictors related to negative outcomes, and identify high risk patients who need priority attention in order to prevent future failure of treatment in HIV patients.
METHODS: The study was a longitudinal clinical based cohort study of One hundred and forty (140) HIV infected adults who were initially ART naive and commenced ART in June- July 2013 were followed up to June 2014. Three out of the participants were lost to follow up, one participant died and 1 participant was transferred to another treatment centre, while a total of one hundred and thirty-five (135) patients were finally included in the immuno-virologic analysis. Adherence was assessed using both self-report questionnaire and measurement of Mean Cell Volume (MCV) which was obtained using automated haematology analyzer. CD4 counts were analyzed using flow cytometry method and HIV-RNA levels were measured by using the RT-Polymerase Chain Reaction technique.
RESULTS: Incomplete adherence was recorded in 28 (20.7%) of the study participants, immunologic failure (decline in CD4 count to or below baseline or CD4 count change < 50 cells/ul at 12 months) was observed in 39 (28.8%) of the participants. Virologic failure rate (viral load > 400 copies/ml) was 27.4% and immuno-virologic failure rate was 31.9%. Using logistic regression model, immunologic failure was associated with male gender (OR=1.29; p=0.008), non-disclosure of status (OR=1.24; p=0.01), baseline anaemia (OR=1.15; p=0.009) and incomplete adherence by self-report (OR=3.28; p=0.001). Virologic failure was associated with no formal education (OR=2.29; p=0.01), non-disclosure of status (OR=1.04; p = < 0.01), non-adherence (OR=2.74; p=0.015), being unemployed (OR=0.57; p=0.04).
CONCLUSIONS: The study observed that immunologic recovery and virologic suppression rate within the first year of treatment was significant, although the rate of incomplete adherence obtained still needs improvement. Effort to promote social coping particularly to patients who were unemployed, re-strategizing on improving patient education and counseling especially to patients with no formal education, focusing on campaigns against stigmatization will help in addressing predictors of negative immuno-virologic outcomes. Baseline HIV-RNA level should also be considered in addition to CD4 testing in order to identify virological failure and thus preventing the emergence of drug resistance in HIV/AIDS management.
Keywords: Incomplete adherence; immuno-virologic failure; HIV patients; Osun state.